Microfluidic and Organ-on-a-chip-based Technologies for Diabetes Therapy and Research

Archive ouverte

Morisseau, Lisa | Messelmani, Taha | Essaouiba, Amal | Sakai, Yasuyuki | Le Goff, Anne | Legallais, Cécile | Leclerc, Eric | Jellali, Rachid

Edité par CCSD ; Royal Society of Chemistry -

International audience. Diabetes is a severe and complex disease with a high prevalence worldwide. Over the last few years, scientists have worked hard to understand the physiopathology of the disease, develop new treatments and diagnosis tools, and improve the quality of life of diabetic patients. Recently, there has been increased focus on using microfluidic technologies in biomedical applications, especially in diabetes research. In this chapter, we present an overview of the main microfluidic technologies related to diabetes research and how they can help solve several of the issues associated with this disease. We start by introducing diabetes, its characteristics, and its treatments. We continue with microfluidic concepts and the materials and manufacturing methods used to develop the microdevices. The main section of the chapter is dedicated to applications of microfluidic technologies in diabetes research, including sensors and diagnosis tools, pancreatic cell encapsulation for transplantation and the organ-on-chip approach. Finally, we conclude the chapter with the perspectives for potential future developments in microfluidic technologies for diabetes and metabolic syndrome research.

Suggestions

Du même auteur

Liver organ-on-chip models for toxicity studies and risk assessment

Archive ouverte | Messelmani, Taha | CCSD

International audience. The liver is a key organ that plays a pivotal role in metabolism and ensures a variety of functions in thebody, including homeostasis, synthesis of essential components, nutrient storage, and...

Microwell-based pancreas-on-chip model enhances genes expression and functionality of rat islets of Langerhans

Archive ouverte | Essaouiba, Amal | CCSD

International audience. Organ-on-chip technology is a promising tool for investigating physiological in vitro responses in drug screening development, and in advanced disease models. Within this framework, we invest...

Investigation of the Exometabolomic Profiles of Rat Islets of Langerhans Cultured in Microfluidic Biochip

Archive ouverte | Essaouiba, Amal | CCSD

International audience. Diabetes mellitus (DM) is a complex disease with high prevalence of comorbidity and mortality. DM is predicted to reach more than 700 million people by 2045. In recent years, several advanced...

Chargement des enrichissements...